{"id":2325,"date":"2008-03-14T22:58:20","date_gmt":"2008-03-15T02:58:20","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=2325"},"modified":"2008-03-14T22:58:20","modified_gmt":"2008-03-15T02:58:20","slug":"vacuna-tetravalente-vph-gardasil-nota-de-la-emea","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/2325","title":{"rendered":"Vacuna tetravalente VPH (Gardasil): nota de la EMEA"},"content":{"rendered":"<p>Estimadas y estimados,<\/p>\n<p>El Comit\u00e9 de Medicamentos Humanos (CHMP) de la EMEA acaba de publicar y distribuir esta nota informando sobre los casos de reacciones adversas en la Union Europea, relacionados con Gardasil (vacuna tetravalente de virus de papiloma humano), que han ocurrido: 2 muertes en Austria y en Alemania.<\/p>\n<p><!--more--> <\/p>\n<p>Indica que la estimacion de vacunadas es de 1,5 millones en Europa.<\/p>\n<p>La nota en:<\/p>\n<p><a href=\"http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/gardasil\/Gardasil_press_release.pdf\" target=\"_blank\">www.emea.europa.eu<\/a><\/p>\n<p>Un abrazo,<\/p>\n<p>Mariano Madurga<\/p>\n<p>AGEMED.es<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Estimadas y estimados, El Comit\u00e9 de Medicamentos Humanos (CHMP) de la EMEA acaba de publicar y distribuir esta nota informando sobre los casos de reacciones adversas en la Union Europea, relacionados con Gardasil (vacuna tetravalente de virus de papiloma humano), que han ocurrido: 2 muertes en Austria y en Alemania.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-2325","post","type-post","status-publish","format-standard","","category-farmacologia"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/2325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=2325"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/2325\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=2325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=2325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=2325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}